Dosing frequency and adherence to antipsychotic medications

Psychiatric Services

Volumn 59, Issue 10, 2008, Pages 1207-1210

  Pfeiffer, Paul N ^a,b,c   Ganoczy, Dara ^a   Valenstein, Marcia ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c SMITREC/VA Ann Arbor Center for Excellence   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DRUG DOSE INCREASE; DRUG DOSE REGIMEN; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRESCRIPTION; SCHIZOPHRENIA; SUBSTANCE ABUSE;

EID: 53549128133     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/ps.2008.59.10.1207     Document Type: Article

References (15)

1. Kim S, Yoon J, Choi S: Survey of medication adherence in patients with schizophrenia - Korean ADHES data. Human Psychopharmacology: Clinical and Experimental 21:533-537, 2006
2. Gilmer TP, Dolder CR, Lacro JP, et al: Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. American Journal of Psychiatry 161:692-699, 2004
3. Valenstein M, Copeland LA, Blow FC, et al: Pharmacy data identifies poorly adherent patients at increased risk for admission. Medical Care 40:630-639, 2002
4. Weiden PJ, Kozma C, Grogg A, et al: Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatric Services 55:886-891, 2004
5. Fenton WS, Blyler CR, Heinssen RK: Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophrenia Bulletin 23:637-651, 1997
6. Lacro JP, Dunn LB, Dolder CR, et al: Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. Journal of Clinical Psychiatry 63:892-909, 2002
7. Buchanan A: A two-year prospective study of treatment compliance in patients with schizophrenia. Psychological Medicine 22:787-797, 1992
8. Diaz E, Neuse E, Sullivan MC, et al: Adherence to conventional and atypical antipsychotics after hospital discharge. Journal of Clinical Psychiatry 65:354-360, 2004
9. Nakonezny P, Byerly M: Electronically monitored adherence in outpatients with schizophrenia or schizoaffective disorder: a comparison of first- vs second-generation antipsychotics. Schizophrenia Research 82:107-114, 2006
10. Remington G, Kwon J, Collins A, et al: The use of electronic monitoring (MEMS) to evaluate antipsychotic compliance in outpatients with schizophrenia. Schizophrenia Research 90:229-237, 2007
11. Woltmann EM, Valenstein M, Welsh D: Using pharmacy data on partial adherence to inform clinical care of patients with serious mental illness. Psychiatric Services 58:864-867, 2007
12. Valenstein M, Blow FC, Copeland LA: Poor antipsychotic adherence among patients with schizophrenia: medication and patient factors. Schizophrenia Bulletin 30:255-264, 2004
13. Lieberman JA, Stroup TS, McEvoy JP, et al.: Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine 353:1209-1223, 2005.
14. Desai RA, Rosenheck RA, Rothbard A: Cross-system service use among VA mental health patients living in Philadelphia. Administration and Policy in Mental Health 28:299-309, 2001
15. Desai RA, Rosenheck RA: The impact of managed care on cross-system use of mental health services by veterans in Colorado. Psychiatric Services 53:1599-604, 2002